FDA Drug Recalls

Recalls / Class II

Class IID-0411-2026

Product

Dry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL OZ (15 mL) bottles; a) GERI CARE, Distributed by: Gericare Pharmaceuticals Corp., Lakewood, NJ 08701, NDC 57896-181-05; b) TopCare health, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELKGROVE VILLAGE, IL 60007, UPC 0 36800 36100 3; c) Rite Aid, DISTRIBUTEDBY: RITE AID, Camp Hill, PA 17011, NDC 11822-1067-2; d) LEADER DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.myleader.com, NDC 70000-0502-1; e) Discount drug mart, Discount Drug Mart Food Fair, Medina, OH 44256, UPC 0 93351 01156 6; f) H-E-B, MADE WITH PRIDE & CARE FOR H-E-B, SAN ANTONIO, TX 78204, UPC 0 41220 43741 2; g) Foster & Thrive, Distributed by: McKesson Corp., via Strategic Sourcing Services LLC, Memphis, TN 38141, www.fosterandthrive.com, NDC 70677-1158-1; h) meijer, DIST. BY MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544, www.meijer.com, NDC 41250-718-01; i) DG health Sterile, DISTRIBUTED BY OLD EAST MAIN CO., GOODLETTSVILLE, TN 37072, UPC 0 95072 02656 0; j) Harris Teeter, Eye Drops, Artificial Tears, PROUDLY DISTRIBUTED BY: HARRIS TEETER, LLC, MATHEWS, NC 28105, UPC 0 72036 71303 2; k) exchange select, Manufactured for your Military Exchanges by: KC Pharmaceuticals, Inc., Pomona, CA 91768, UPC 6 14299 05620 6; l) Good Neighbor Pharmacy, Distributed By AmerisourceBergen, Conshohocken, PA 19428, NDC 46122-605-05

Brand names
Artificial Tears, Rite Aid Eye Drops Dry Eye Relief, Leader Dry Eye Relief Eye Drops, Foster And Thrive Advanced Relief Eye Drops, Meijer Dry Eye Relief, Gnp Eye Drops Dry Eye Relief
Generic names
Glycerin, Glycerin, Hypromellose, Polyethylene Glycol 400, Polyethylene Glycol 400, Tetrahydrozoline Hcl
Active ingredients
Glycerin, Hypromelloses, Polyethylene Glycol 400, Hypromellose, Unspecified, Tetrahydrozoline Hydrochloride
Route
Ophthalmic
NDCs
57896-181, 11822-1067, 70000-0502, 70677-1158, 41250-718, 46122-605
FDA application
M018
Affected lot / code info
Lot: a) LT24E01, LT24E02, LT24E03, Exp.: 05/31/26; LT24F01, Exp.: 06/30/26; LT24G01, Exp.: 07/31/26; LT24M01, LT24M02, Exp.: 10/31/26; b) LT24E03, Exp.: 05/31/26; LT24F01, Exp.:06/30/26; LT24G01, Exp.:07/31/26; LT24M02, Exp.: 10/31/26; c) LT24F01, Exp.: 06/30/26; d) LT24F01, Exp.: 06/30/26; LT24G01, Exp.: 07/31/26; e) LT24F01, Exp.: 06/30/26; f) LT24F01, Exp.: 06/30/26; LT24G01, Exp.: 07/31/26; g) LT24F01, Exp.: 06/30/26; LT24G01, Exp.: 07/31/26; h) LT24F01, Exp.: 06/30/26; i) LT24F01, Exp.: 06/30/26; LT24G01, Exp.: 07/31/26; j) LT24F01, Exp.: 06/30/26; k) LT24G01, Exp.: 07/31/26; L) LT24F01, Exp.: 06/30/26; m)

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
K.C. Pharmaceuticals, Inc
Manufacturer
Geri-Care Pharmaceuticals, Corp
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
3420 Pomona Blvd, Pomona, California 91768-3236

Distribution

Quantity
1,023,096 bottles
Distribution pattern
Nationwide in the US

Timeline

Recall initiated
2026-03-03
FDA classified
2026-03-31
Posted by FDA
2026-04-08
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0411-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.